Drugs / DC cell suspension
last change Aug 2018 re-read 9 days ago

DC cell suspension

Cell therapy

Developed for
lung cancer
Investigated by
Ningbo Cancer Hospital

Trials 1

20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT02873416 Aug 2016 → Mar 2018 lung cancer Ningbo Cancer Hospital Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DC cell suspension “Precision Cells DC cell suspension (1×10\*7 DC+physiological saline + 0.25% human bloodalbumin)1ml for each infusion, subcutaneous injection for each infusion, 3 cycles, each...” NCT02873416 ↗
Modality Cell therapy “DC cell suspension” NCT02873416 ↗